A new study by researchers from Fogarty International Center at the National Institutes of Health in the United States of America has revealed that a third of antimalarial drugs in South East Asia and sub-Saharan Africa are counterfeit.
As a result, more than 3.3 billion people risk of malaria in the 106 endemic countries may soon develop resistance to malaria drugs. That means that even the most effective drugs would no longer be able to cure the disease in such people. Therefore, the number of people who die every year from this tropical disease will inevitably shoot up. Yet already, about 1.2 million people die every year from malaria infection.
...